• Aucun résultat trouvé

Haemophilus influenzae E

N/A
N/A
Protected

Academic year: 2022

Partager "Haemophilus influenzae E "

Copied!
37
0
0

Texte intégral

(1)

WHO/V&B/00.05 ORIGINAL: ENGLISH

DISTR.: GENERAL

Haemophilus influenzae E

(2)

WHO/V&B/00.05

:

www.who.int/vaccines-documents/

World Health Organization Department of Vaccines and Biologicals

CH-1211 Geneva 27, Switzerland

iFax: +41 22 791 4227iE-mail: vaccines@who.int i

©

(3)

Y YL

+LE

+LE

+LE

+LE

+LE

"

(4)

+LE

"

+LE"

"

+LE

+LE

+DHPRSKLOXVLQIOXHQ]DH E

+LE

+LE

(5)

+LE

(6)

(7)

+DHPRSKLOXV LQIOXHQ]DH

DI E

+DHPRSKLOXVLQIOXHQ]DH E+LE

+LE

+LE

+LE

+LE +LE

+LE

+LE

+LE

(8)

+LE

+LE

+DHPRSKLOXV LQIOXHQ]DH E D E F G H I

E

+DHPRSKLOXVLQIOXHQ]DH +LE

+LE

+LE

+LE

+LE

+LE

(9)

+LE

+LE

+LE

+LE

+LE

(10)

+LE

+LE

+LE

+LE

+LE

+LE

+LE

+LE

+LE

+DHPRSKLOXV LQIOXHQ]DH E

+DHPRSKLOXV LQIOXHQ]DH

+LE

+LE

(11)

+LE

+LE

+LE

3

Hib

32 9,5-13,8

9,7 +LE

32 13,8 154,0

11,9 +LE

9,7 5,3

3URGXFW,QIRUPDWLRQ6KHHWV

+LE ƒƒ

+LE

+LE ƒƒ&

(12)

+LE

ƒƒ&

+LE

+LE

+LE

+LE

+LE +LE

+LE

(13)

+LE +LE +LE

+LE

+LE

(14)

+LE

+LE

+LE "

+LE

+LE

+LE

+LE +LE

+LE

(15)

+LE +LE

+LE

+LE

"

+LE

+LE

+LE"

+LE

(16)

+LE

+LE

+LE

+LE

(17)

+LE

+LE +LE

+LE

"

+LE

+LE

a)

b)

c)

d)

e)

+LE

+LE

(18)

+LE

+LE

(19)

5

+LE

+LE

+LE

+LE

+LE

+LE

(20)

+LE +LE +LE

+LE

+LE

+LE +LE

+LE

+LE

³ +LE

(21)

³

+LE

+LE

+LE

(22)

+LE

+LE

+LE

+LE

+LE

+LE

+LE

+LE

+LE

+LE

+LE

(23)

+LE

+LE

+LE

+LE

+LE

+LE

+LE +LE "

+LE

"

+LE

+LE "

"

+LE

+LE +LE

"

+LE

(24)

+LE

+LE

+LE

+LE

+LE

+LE

+LE

(25)

Generic protocol for population-based surveillance of Haemophilus influenzae type B. WHO/VRD/GEN/95.05.

+LE

+LE

Product Information Sheets Edition 2000. WHO/V&B/00.13

WHO/V&B/99.25.

Surveillance of adverse events following immunization: Field guide for managers of immunization programmes. WHO/EPI/TRAM/93.02 Rev.1

The WHO Position Paper on Haemophilus influenzae type b conjugate vaccines.

Weekly Epidemiological Record, 1998. 73:64-71.

Vaccine Vial Monitor and Opened Vial Policy: Questions and Answers.

WHO/EPI/LHIS/96.01.

WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions. WHO/V&B/00.09.

(26)

Haemophilus influenzae b

1

Haemophilus influenzae b ( Hib)

HLE

+LE

+LE

+LE

+LE

(

+LE

+LE

+LE +LE

+LE

+LE

+LE

___________________

(WH0/EPI/GEN/98.01 Rev.1).

(27)

Haemophilus influenzae b +LE

+LE

CIE).

+LE

+LE

+LE+LE

(28)

Haemophilus influenzae b+LE

+LE

+LE

•

,

•

•

(29)

Haemophilus influenzae b ( Hib)

+LE

+LE

+LE

+LE

WHO/VRD/GEN/95.05.

(30)

-

+LE

+LE

+LE" "

+LE +DHPRSKLOXVLQIOXHQ]DH E

+LE

+LE

+LE

"

+LE

(31)

+LE

+LE

+LE

"

+LE

+LE

+LE "

"

+LE

+LE "

+LE

+LE

+LE

+LE "

+LE

+LE

(32)

+LE"

+LE +LE +LE

+LE"

+LE

" "

+LE

+LE

"

"

+LE

+LE

(33)

+LE"

+LE

+LE"

+LE

+LE

+LE"

+LE

+LE

+LE"

+LE +LE

"

"

+LE

(34)

+LE

+LE

"

+LE"

+LE +LE

+LE

(35)

+LE

+LE

+LE" "

+LE +DHPRSKLOLXVLQIOXHQ]DH E

+LE

+LE

+LE "

+LE

+LE" "

+LE

(36)

+LE

+LE

"

+LE

+LE

+LE"

+LE

+LE

+LE +LE

+LE"

+LE "

+LE

" "

+LE

(37)

+LE"

+LE

"

+LE

+LE"

+LE

Références

Documents relatifs

commencer aÁ se poser cette question, puisque que leurs « capaciteÂs nationales » supporteraient aiseÂment le couÃt du vaccin et de son administration ; en outre, meÃme si

This study was done to estimate the Hib carrier rate among children under 6 years old attending day-care centres in Tehran to answer the question whether Hib vac- cination is

2 Cette estimation du nombre de décès par infection aiguë à Hib des voies respiratoires basses est environ dix fois plus élevée que le nombre estimé de décès par méningite à

In situations where there is a particularly high risk of mortality among children under age 9 months, such as refugee camps, hospitalized infants, and HIV-infected infants, two doses

It notes that the term levonorgestrel-releasing intrauterine device and its currently used acronym, LNG-IUD, differentiate this method from the copper-bearing intrauterine

• Review of relevant policies, for example, providing MCV1 to children older than 1 year of age, school entry vaccination screening to ensure all children have received two doses

Safety means a workplace where staff are free from bullying and harassment, or the fear of harassment, in all its ugly forms, and when such behaviour makes itself

How to create an attractive and supportive working environment for health professionals, Copenhagen, World Health Organization Regional Office for Europe: Health